Stock Comparison
HLN vs RDY
Haleon plc and Dr. Reddy’s Laboratories Ltd ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$43.55B
$10.42B
P/E (TTM)
20.2
29.8
Forward P/E
18.0
27.2
Price/Sales
3.9
0.0
Price/Book
2.0
2.6
EV/EBITDA
14.0
14.5
Dividend Yield
1.93%
0.66%
Profitability
Net Margin
14.43%
12.72%
Operating Margin
21.32%
14.74%
Return on Equity
10.10%
8.84%
Return on Assets
5.08%
4.01%
Growth (YoY)
Revenue Growth
2.20%
-5.60%
Earnings Growth
-4.50%
-68.70%
Price & Risk
Beta
0.2
0.2
52-Week High
$11.12
$15.40
52-Week Low
$8.61
$11.40
Analyst Target
$11.99
$13.54
Compare HLN and RDY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.